RK
Ravi Kant Yadav
About Ravi Kant Yadav
Data last updated:
Ravi Kant Yadav is a Director at Weehum Pharmaceutical Private Limited (since 2020). The company operates in Pharma. Weehum Pharmaceutical Private Limited reported revenue of ₹46,180 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Weehum Pharmaceutical Private Limited U51900JH2020PTC015372 | Director | 20 Oct 2020 | 2020 | ₹46,180 (FY 2025) | Active |
Board colleagues of Ravi Kant Yadav
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kaushal Kant Verma | 09608717 | Weehum Pharmaceutical Private Limited | Director |
| Pinki Kumari | 08926410 | Weehum Pharmaceutical Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Kant Yadav
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Kant Yadav
Ravi Kant Yadav currently holds 1 directorship: Weehum Pharmaceutical Private Limited (Director, since 20 Oct 2020, revenue ₹46,180 (FY 2025)).
Ravi Kant Yadav was first appointed on 20 Oct 2020 as Director at Weehum Pharmaceutical Private Limited.
The current boards of Ravi Kant Yadav's companies include Kaushal Kant Verma (Weehum Pharmaceutical Private Limited), Pinki Kumari (Weehum Pharmaceutical Private Limited).